Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Syncona Share News (SYNC)
SYNC Share
Price
SYNC Share
News
SYNC Share
Chat
SYNC Share
Trades64
SYNC
Live RNS
SYNC Share
Charts
SYNC Level 2
Console
SYNC Live
Share Price
SYNC Broker
Ratings
SYNC Directors
Deals
SYNC Financial
Diary
SYNC
Fundamentals
SYNC Short
Positions
SYNC
Media
SYNC Company
Research
SYNC Company
Timeline
Syncona Information
Share Price Information for Syncona (SYNC)
Share Price is delayed by 15 minutes
Get Live Data
95.40
-0.80 (-0.83%)
Bid:
96.00
Ask:
96.80
Spread:
0.80 (0.833%)
Market Cap:
£580.22m
Last checked at -
Last checked at 
Intraday Syncona Share Chart
Syncona News
25 Mar 2021
Syncona portfolio firm Achilles Therapeutics prices US share offering
Syncona portfolio firm Achilles Therapeutics prices US share offering
4 Mar 2021
TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance
TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance
2 Mar 2021
IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO
IN BRIEF: Syncona investee Achilles Therapeutics files for US IPO
12 Feb 2021
IN BRIEF: Syncona's Gyroscope Reports Positive Results From GT005 Test
IN BRIEF: Syncona's Gyroscope Reports Positive Results From GT005 Test
11 Feb 2021
Syncona Net Asset Value Dips In Third Quarter, Invests More In Quell
Syncona Net Asset Value Dips In Third Quarter, Invests More In Quell
11 Feb 2021
Syncona makes decent progress in December quarter
(Sharecast News) - Healthcare investment company Syncona updated the market on its latest quarter on Thursday, reporting clinical, financial and opera...
10 Feb 2021
Syncona Investee Autolus Nets USD100 Million From ADS Offer
Syncona Investee Autolus Nets USD100 Million From ADS Offer
10 Feb 2021
Syncona upbeat on Autolus US public offering pricing
(Sharecast News) - Healthcare investor Syncona said on Wednesday that its portfolio company Autolus Therapeutics has priced its underwritten public of...
Follow the stocks
